This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sullivan, C. M Articles by Grant, P. J Search for Related Content PubMed PubMed Citation Articles by Sullivan, C. M Articles by Grant, P. J Social Bookmarking                         What's this?

RAGE polymorphisms and the heritability of insulin resistance: the Leeds Family Study

Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics, Health and Therapeutics, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds, LS2 9JT, UK

T. Simon Futers

Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics, Health and Therapeutics, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds, LS2 9JT, UK

Jennifer H Barrett

Genetic Epidemiology Division, Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, LS9 7TF, UK

Barry I Hudson

The Division of Surgical Science, Columbia University, New York, NY, US

Mark S Freeman

Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics, Health and Therapeutics, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds, LS2 9JT, UK

Peter J Grant

Academic Unit of Molecular Vascular Medicine, Leeds Institute of Genetics, Health and Therapeutics, The LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds, LS2 9JT, UK

Activation of the receptor for advanced glycation end-products (RAGE) leads to a cascade of pro-inflammatory and pro-coagulant responses which are important in the pathogenesis of the vascular complications of diabetes mellitus. It is known that pro-inflammatory mechanisms underpin the development of type 2 diabetes. Our hypothesis is that RAGE may be involved in the evolution of insulin resistance in addition to mediating glucotoxic complications of diabetes mellitus.

Methods To investigate the relationship between RAGE allelic variation and insulin resistance, the Gly82Ser variant and three promoter variants (429, 374, 63 bp deletion) were studied in 480 subjects of known relationship from 89 families characterised for insulin resistance (using homeostasis model assessment [HOMA]) and for atherothrombotic risk. Carriage of the-429 C allele was weakly associated with increased insulin resistance (p=0.02) when pedigree analysis was performed using SOLAR software.

Results Insulin resistance was estimated to have a heritability of 25.8% before the addition of covariates. Analysis of the relationship between RAGE and insulin resistance indicated that the-429 polymorphism reduced the unexplained heritability of insulin resistance after adjusting for covariates (age, sex, body mass index) from 17.5% of the total variance to 15.6% of the total variance.

Conclusions These preliminary results indicate that the RAGE gene may affect the development of insulin resistance or be in linkage disequilibrium with a locus involved in this process.

Key Words: RAGE • insulin resistance • advanced glycation end-products • polymorphism • population studies

Diabetes and Vascular Disease Research, Vol. 2, No. 1, 42-44 (2005)
DOI: 10.3132/dvdr.2005.005


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. J. Elder, A. H. Lichtenstein, A. G. Pittas, S. B. Roberts, P. J. Fuss, A. S. Greenberg, M. A. McCrory, T. J. Bouchard Jr., E. Saltzman, and M. C. Neale Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome J. Lipid Res., September 1, 2009; 50(9): 1917 - 1926. [Abstract] [Full Text] [PDF]